16-88643570-G-A

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong

The NM_000101.4(CYBA):​c.371C>T​(p.Ala124Val) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000111 in 1,532,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000094 ( 0 hom. )

Consequence

CYBA
NM_000101.4 missense, splice_region

Scores

8
8
3
Splicing: ADA: 0.01021
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4O:1

Conservation

PhyloP100: 6.66
Variant links:
Genes affected
CYBA (HGNC:2577): (cytochrome b-245 alpha chain) Cytochrome b is comprised of a light chain (alpha) and a heavy chain (beta). This gene encodes the light, alpha subunit which has been proposed as a primary component of the microbicidal oxidase system of phagocytes. Mutations in this gene are associated with autosomal recessive chronic granulomatous disease (CGD), that is characterized by the failure of activated phagocytes to generate superoxide, which is important for the microbicidal activity of these cells. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM1
In a intramembrane_region (size 36) in uniprot entity CY24A_HUMAN there are 5 pathogenic changes around while only 2 benign (71%) in NM_000101.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.994
PP5
Variant 16-88643570-G-A is Pathogenic according to our data. Variant chr16-88643570-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 68212.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-88643570-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CYBANM_000101.4 linkc.371C>T p.Ala124Val missense_variant, splice_region_variant 6/6 ENST00000261623.8 NP_000092.2 P13498B4DT46
CYBAXM_011522905.4 linkc.*1596C>T 3_prime_UTR_variant 6/6 XP_011521207.1 H3BNP7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CYBAENST00000261623.8 linkc.371C>T p.Ala124Val missense_variant, splice_region_variant 6/61 NM_000101.4 ENSP00000261623.3 P13498

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152060
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000773
AC:
1
AN:
129404
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
70926
show subpopulations
Gnomad AFR exome
AF:
0.000157
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000942
AC:
13
AN:
1380352
Hom.:
0
Cov.:
37
AF XY:
0.00000734
AC XY:
5
AN XY:
681390
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000280
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000102
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152060
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74264
show subpopulations
Gnomad4 AFR
AF:
0.0000966
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189
ExAC
AF:
0.0000285
AC:
2

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 03, 2024This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 124 of the CYBA protein (p.Ala124Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with chronic granulomatous disease (PMID: 10914676, 30470980, 35140711). ClinVar contains an entry for this variant (Variation ID: 68212). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Studies have shown that this missense change alters CYBA gene expression (PMID: 28941186, 36606663). This variant disrupts the p.Ala124 amino acid residue in CYBA. Other variant(s) that disrupt this residue have been observed in individuals with CYBA-related conditions (PMID: 18546332, 30470980), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMar 22, 2024- -
Polyglandular autoimmune syndrome, type 1 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 25, 2024Variant summary: AIRE c.371C>T (p.Pro124Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00026 in 246854 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in AIRE causing Autoimmune Polyglandular Syndrome Type 1 (0.00026 vs 0.0028), allowing no conclusion about variant significance. c.371C>T has been reported in the literature in individuals affected with Autoimmune Polyglandular Syndrome Type 1 (Zheng_2020, Ruan_2021), however, these reports do not provide unequivocal conclusions about association of the variant with Autoimmune Polyglandular Syndrome Type 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters have assessed the variant since 2014: one classified the variant as uncertain significance and one as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Chronic granulomatous disease Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 25, 2024Variant summary: CYBA c.371C>T (p.Ala124Val), located near a canonical splice site, results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 7.7e-06 in 129404 control chromosomes (gnomAD). c.371C>T has been reported in the literature in multiple individuals affected with Chronic Granulomatous Disease (e.g. Ishibashi_2000, Jakobsen_2012, Koker_2013, Kulkarni_2018, Chiu_2021). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 35140711, 10914676, 22924696, 23910690, 30470980). ClinVar contains an entry for this variant (Variation ID: 68212). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Other:1
not provided, no classification providedliterature onlyUniProtKB/Swiss-Prot-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.37
CADD
Uncertain
25
DANN
Benign
0.94
DEOGEN2
Pathogenic
0.95
D
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.81
T
M_CAP
Pathogenic
0.62
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
0.84
D
MutationAssessor
Uncertain
2.7
M
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-3.4
D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.011
D
Sift4G
Uncertain
0.023
D
Polyphen
1.0
D
Vest4
0.85
MutPred
0.96
Loss of catalytic residue at A124 (P = 0.2363);
MVP
0.97
MPC
0.33
ClinPred
0.77
D
GERP RS
4.2
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.7
Varity_R
0.38
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs179363894; hg19: chr16-88709978; API